NLRP3 and systemic lupus erythematosus: These discoveries establish NLRP3‐mediated pyroptosis as a central mechanism driving cartilage destruction in the context of SLE inflammatory joint disease, offering potential therapeutic targets for mitigating AC degeneration and alleviating hip arthritis progression specifically in SLE patients.